Yi-Long Wu, n/a

Chief Physician
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China, China (People's Republic)

Poster(s):

• (301) Zongertinib in patients with pretreated human epidermal growth factor receptor 2-mutant advanced non–small cell lung cancer: Beamion LUNG-1
  Wednesday, October 29, 2025